Eligi
Med
Ensayos clínicos
Suscripción
Sobre EligiMed
Ensayos Clínicos de Gastroenterología | EligiMed
Ensayos clínicos
8.676 ensayos encontrados
Por invitación
ClinicalTrials.gov
EuroSIDA Prospective Observational Cohort Study on Clinical and Virological Outcome of European Patients Infected With HIV
OBSERVATIONAL
Inicio: 1 de ene de 1994
ID: NCT02699736
Completado
Fase 3
ClinicalTrials.gov
An Open-label Extension Study to Evaluate the Long-term Safety and Efficacy of Maralixibat in the Treatment of Subjects With Progressive Familial Intrahepatic Cholestasis (PFIC)
INTERVENTIONAL
Inicio: 8 de ene de 2020
ID: NCT04185363
Completado
Fase 3
ClinicalTrials.gov
Randomized, Double-Blind, Multicenter Study to Compare the Safety and Efficacy of Viramidine to Ribavirin in Treatment-Naive Patients With Chronic Hepatitis C
INTERVENTIONAL
Inicio: 1 de jun de 2004
ID: NCT00093093
Completado
Fase 3
ClinicalTrials.gov
A Randomized, Double-blind, Active-controlled, Parallel Group, Stratified, Multi-center, 12-Week Study Comparing the Safety and Efficacy of Fluticasone and Formoterol Combination (FlutiForm™ 250/10ug Twice Daily) in a Single Inhaler (SkyePharma HFA pMDI) With the Administration of Fluticasone (250ug Twice Daily) Alone in SkyePharma HFA pMDI and Flovent® HFA pMDI in Adolescent and Adult Patients With Moderate to Severe Asthma
INTERVENTIONAL
Inicio: 1 de mar de 2008
ID: NCT00649025
Reclutando
Fase 3
ClinicalTrials.gov
A Phase 3, Multicenter, Open-label, Basket, Long-term Extension Study of Ustekinumab in Pediatric Clinical Study Participants (2 to <18 Years of Age)
INTERVENTIONAL
Inicio: 18 de oct de 2021
ID: NCT05092269
Completado
Fase 2
ClinicalTrials.gov
SR121463B in Cirrhotic Ascites Treatment With Normonatraemia: A Placebo-Controlled, Dose-Comparison Study
INTERVENTIONAL
Inicio: 1 de abr de 2004
ID: NCT00501566
Terminado
Fase 3
ClinicalTrials.gov
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of Oral Ozanimod as Maintenance Therapy for Moderately to Severely Active Crohn's Disease
INTERVENTIONAL
Inicio: 27 de jun de 2018
ID: NCT03464097
Completado
Fase 4
ClinicalTrials.gov
EVALUATION OF AN ALTERNATIVE TECHNIQUE FOR THE APPLICATION OF SODIUM FLUOROPHOSPHATE: A 2-YEARS DOUBLE-BLIND RCT
INTERVENTIONAL
Inicio: 1 de abr de 2017
ID: NCT05810389
Terminado
ClinicalTrials.gov
Is the Placental Transfusion Volume Influenced by the Position of the New Born at Birth? a Pilot Study
INTERVENTIONAL
Inicio: 1 de oct de 2010
ID: NCT01497340
Terminado
Fase 3
ClinicalTrials.gov
An Open-Label Extension and Safety Monitoring Study of Moderate to Severe Ulcerative Colitis Patients Previously Enrolled in Etrolizumab Phase II/III Studies
INTERVENTIONAL
Inicio: 15 de sept de 2014
ID: NCT02118584
Desconocido
ClinicalTrials.gov
Ischemic Preconditioning Versus Intermittent Portal Triad Clamping in Liver Resection. Prospective Randomized Comparison
INTERVENTIONAL
Inicio: 1 de jul de 2011
ID: NCT01432548
Terminado
Fase 3
ClinicalTrials.gov
An Open-label, Randomized Phase 3 Study of the Efficacy and Tolerability of Linifanib (ABT-869) Versus Sorafenib in Subjects With Advanced Hepatocellular Carcinoma (HCC)
INTERVENTIONAL
Inicio: 1 de ene de 2010
ID: NCT01009593
Terminado
Fase 2
ClinicalTrials.gov
A 12-month, Open-label, Multicenter, Randomized, Safety, Efficacy, Pharmacokinetic (PK) and Pharmacodynamic (PD) Study of Two Regimens of Anti-CD40 Monoclonal Antibody, CFZ533 vs. Standard of Care Control, in Adult de Novo Liver Transplant Recipients With a 12-month Additionalr Follow-up and a Long-term Extension (CONTRAIL I)
INTERVENTIONAL
Inicio: 7 de oct de 2019
ID: NCT03781414
Activo, no recluta
Fase 3
ClinicalTrials.gov
A Phase 3 Multicenter, Long-Term Extension Study to Evaluate the Safety and Efficacy of Upadacitinib (ABT-494) in Subjects With Ulcerative Colitis
INTERVENTIONAL
Inicio: 31 de ene de 2017
ID: NCT03006068
Completado
Fase 2
ClinicalTrials.gov
Randomized Embolization Trial for NeuroEndocrine Tumor Metastases to the Liver
INTERVENTIONAL
Inicio: 1 de mar de 2016
ID: NCT02724540
Completado
Fase 3
ClinicalTrials.gov
A 12 Week Study to Evaluate the Effect of Fluticasone Furoate (FF, GW685698)/Vilanterol (VI, GW642444) 100/25 mcg Inhalation Powder Delivered Once Daily Via a Novel Dry Powder Inhaler (NDPI) on Arterial Stiffness Compared With Tiotropium Bromide 18 mcg Delivered Once Daily Via a HandiHaler in Subjects With Chronic Obstructive Pulmonary Disease (COPD).
INTERVENTIONAL
Inicio: 30 de jun de 2011
ID: NCT01395888
Completado
Fase 3
ClinicalTrials.gov
Extension Study to the Multicenter, Open-label, Randomized, Controlled Study CRAD001H2304 to Evaluate the Long-term Efficacy and Safety of Concentration-controlled Everolimus in Liver Transplant Recipient
INTERVENTIONAL
Inicio: 31 de mar de 2010
ID: NCT01150097
Completado
Fase 3
ClinicalTrials.gov
RECITE: A Phase 3 Randomized Placebo-controlled Double-blind Study of Romiplostim for the Treatment of Chemotherapy- Induced Thrombocytopenia in Patients Receiving Oxaliplatin-based Chemotherapy for Treatment of Gastrointestinal, Pancreatic, or Colorectal Cancer
INTERVENTIONAL
Inicio: 30 de sept de 2019
ID: NCT03362177
Completado
ClinicalTrials.gov
A Smoking Cessation Intervention During Pregnancy in Argentina and Uruguay
INTERVENTIONAL
Inicio: 1 de oct de 2011
ID: NCT01852617
Completado
Fase 4
ClinicalTrials.gov
A 24-week Treatment, Multi-center, Randomized, Double-blind, Double-dummy, Parallel Group Study to Compare Umeclidinium/Vilanterol, Umeclidinium, and Salmeterol in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
INTERVENTIONAL
Inicio: 16 de jun de 2017
ID: NCT03034915
Anterior
1
...
25
26
27
...
434
Siguiente
Filtros